Xi Jinping slept on a straw mat in a flea-infested cave in rural China for seven years… It was part of his "re-education." You see, Xi's father was a founding member of the Communist Party of China. But this hurt, rather than helped, Xi when his father fell from power. He was seen as a privileged "princeling." And the Communist Party didn't want him. Xi underwent years of hard labor in the fields of Liangjiahe to "cleanse" him of his affluent upbringing. The party rejected him 10 times. But it finally accepted him in 1974. Today, Xi is the president of China. And he recently made a statement that will change everything about the Chinese stock market… Let me explain… Last month, Xi became much more than just an influential president…
Top 5 Heal Care Stocks To Invest In Right Now: Flagstar Bancorp, Inc.(FBC)
Advisors’ Opinion:
- [By Dustin Blitchok]
When Alessandro DiNello was named CEO of Flagstar Bancorp Inc (NYSE: FBC) in 2013, the bank was on a financial precipice.
The bank’s business was almost entirely mortgages. As the industry unraveled nationally, Flagstar accepted $267 million in TARP money in 2009 — as well as private equity financing — to maintain solvency.
Top 5 Heal Care Stocks To Invest In Right Now: Freeport-McMoran, Inc.(FCX)
Advisors’ Opinion:
- [By Ben Levisohn]
Freeport-McMoRan (FCX) tumbled to the bottom of the S&P 500 today as the dollar rose and copper prices fell.
Agence France-Presse/Getty Images
Freeport-McMoRandropped 4.9% to $13.31 today, while the S&P 500 fell 0.6% to 2,381.92. The ICE U.S. Dollar Index rose 0.4% today, and
Front Month Comex Copper for March delivery declined 1.7% to $2.6795 today.Axiom Capital’s Gordon Johnson warns that iron ore prices might be ready to drop:
Beware: An Imminent End to an Epic Restock Suggests Iron Ore Prices May Snap Back Toward Fundamentals. Our work suggests ~70% of global iron ore demand can be met at a cash cost of <$23/t; add in $8/t for interest, CAPEX, & other, & we get to a breakeven of $31/t. In addition, w/ inventory restocking & current prices making further investment attractive, despite current excesses, we believe iron ore prices should be ~$40/t (i.e., below marginal costs); in this fashion, w/ Chinese real estate investment on the decline, we view iron ore spot prices >$62/t as a stretch. So what has been propping prices? In our view, one word restocking; first by the mills, undergoing the biggest restocking effort of Chinese steel in >6-yrs., & then by the traders, which have built their iron ore port stocks to a record, w/ days of inventory at a 2.5-yr. high (Ex. 18-19). Yet, w/ data pointing to peak steel inventory, implying risk to n-term ore demand, & the govt probing speculative trading, we see the current restocking cycle as very much so in the later innings
Freeport-McMoRan’s market capitalization fell to $19.2 billion today from $20.2 billion yesterday. It reported a net loss of $4 billion on sales of $14.8 billion in 2016.
- [By WWW.KIPLINGER.COM]
Some energy stocks just cant seem to catch a break and Freeport-McMoRan Inc. (FCX) is one of those energy stocks. As we all know, FCX made some bad moves and decided to get into the oil business just as prices were peaking. That wouldnt be so bad, if it wasnt for the massive debt it took out to buy stakes in the gulf and other regions.
- [By Chris Lange]
The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Freeport-McMoRan Inc. (NYSE: FCX) which jumped 5.1% to $12.90. The stocks 52-week range is $8.76 to $17.06. Volume was 23.36 million which is below the daily average of around 29.12 million shares.
- [By ]
Thats where our own copper comeback play Freeport-McMoRan Inc. (NYSE: FCX) comes into play. You wont hear a lot of talk about copper or FCX in the financial media these days. But if we turn to the charts, its easy to see Dr. Coppers impressive turnaround move that started to unfold earlier this year. After years of pain and suffering, a sustainable rally is in the works.
- [By Ben Levisohn]
Freeport-McMoRan (FCX) ledthe S&P 500 today lower today after metal prices fell on concerns that President Donald J. Trump won’t be able to pass his pro-growth agenda.
Getty Images
Freeport-McMoRandropped 4.7% to $12.21, while the S&P 500 dipped 0.1% to 2,341.59.
Evercore ISI’s Dennis DeBusschere and team discuss the impact of the healthcare failure on risky assists like commodities:
Risk assets are lower globally as the USD continues to lead bond yields, global equities and commodity prices lower. The DXY is down -3% since March 10th and the declines accelerated overnight as investor concerns over the size, timing and likelihood of fiscal stimulus grow. In addition, PBoC Governor Zhou Xiaochuan noted that China is at the end of ultra-easing measures. The recent drumbeat of news from China noting that they are moving away from growth at all costs has helped push commodity prices lower. Declines in copper, iron ore and steel accelerated overnight.
Freeport-McMoRan’s market capitalization fell to $17.6 billion.It reported a net lossof $3.9 billion on sales of $14.6 billion in 2016.
- [By Reuben Gregg Brewer]
In February, the shortest month of the year, copper, gold, and oil company Freeport-McMoRan Inc (NYSE:FCX) saw its shares tumble by nearly 20%. After a roughly 95% price gain in 2016, it was a painful reminder of years past, when Freeport-McMoRan was dealing with the aftermath of an ill-timed oil investment.
Top 5 Heal Care Stocks To Invest In Right Now: Lifeway Foods, Inc.(LWAY)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart for Dean Foods Co shows a positive but not spectacular long term return as small cap Lifeway Foods, Inc (NASDAQ: LWAY) has been more volatile and non-dairy desert stock Tofutti Brands Inc (NYSEMKT: TOF) has given a moderately positive performance:
- [By Jim Robertson]
Last Friday, our Under the Radar Moversnewsletter suggested shorting small capdairy health food product stock Lifeway Foods, Inc (NASDAQ: LWAY):
Top 5 Heal Care Stocks To Invest In Right Now: Gap, Inc. (The)(GPS)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows shares of Lululemon Athletica basically range boundwhile other players in the athletic apparel or yoga space like large capsUnder Armour Inc (NYSE: UA), Nike Inc (NYSE: NKE) and The Gap Inc (NYSE: GPS) have performed better except for the latter:
- [By Leo Sun]
Gap (NYSE:GPS), the parent company of Old Navy, Gap, and Banana Republic, trades at 14 times earnings. It pays a forward yield of 3.9%, which is supported by a payout ratio of 55%. The company has hiked that dividend annually for seven straight years.
- [By Lisa Levin]
Gap Inc (NYSE: GPS) shares dropped 16 percent to $25.74. Gap posted in-line profit for its third quarter. However, the company reported a decline in quarterly sales.
- [By Peter Graham]
Mid cap clothing retailer stockThe Gap Incs (NYSE: GPS)reported Q1 earnings after the market closed Thursday with shares up in premarket trading Old Navy, the company’s biggest brand by revenue,posted its fifth consecutive year of sales growth in 2016. Net sales were flat year over year at$3.4 billion (the translation of foreign currencies into U.S. dollars negatively impacted net sales by about $11 million). Gap Incs comparable sales were up 2% versus a 5% decrease last year with Old Navy Globals comparable salesup 8% versus negative 6% last year; Gap Globals comparable saleswere down4% versus negative 3%last year; and Banana Republic Globals comparable saleswere down4% versus negative 11% last year. Net income was $143 million versus net income of$127 million.
Top 5 Heal Care Stocks To Invest In Right Now: AMAG Pharmaceuticals, Inc.(AMAG)
Advisors’ Opinion:
- [By Lisa Levin]
Shares of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) were down around 36 percent to $22.95. Before the open, the issue company issued FY 2017 sales that surrounded current estimates. Also, the company announced an exclusive licensing agreement with Palatin Technologies, Inc. (NYSE: PTN) for North American rights to Rekyndatm. Raymond James downgraded AMAG Pharmaceuticals from Market Perform to Underperform.
- [By WWW.MONEYSHOW.COM]
Makena is the flagship drug from AMAG Pharmaceuticals (AMAG); the drug helps reduce the risk of preterm birth.
The company’s blood registry preserves newborn stem cells used to treat blood and immune disorders.
